These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15506238)

  • 21. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect.
    Mahfouz MM; Kummerow FA
    Prostaglandins Other Lipid Mediat; 2000 Jul; 62(2):183-200. PubMed ID: 10938412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
    Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR
    J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory mechanisms of dantrolene on platelet aggregation.
    Chou TC; Li CY
    Thromb Res; 1999 Nov; 96(4):299-307. PubMed ID: 10593433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
    Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR
    J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
    Liao CH; Ko FN; Wu CL; Teng CM
    J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis.
    Hsiao G; Chou PH; Shen MY; Chou DS; Lin CH; Sheu JR
    J Agric Food Chem; 2005 Oct; 53(20):7734-40. PubMed ID: 16190625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
    Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH
    Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet effect of demethyldiisoeugenol.
    Liao CH; Ko FN; Kuo YH; Teng CM
    Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways.
    Sheu JR; Hsiao G; Shen MY; Lin WY; Tzeng CR
    Clin Lab Haematol; 2002 Apr; 24(2):121-9. PubMed ID: 11985559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of ginkgolide B on platelet aggregation in a cAMP- and cGMP-dependent manner by activated MMP-9.
    Cho HJ; Nam KS
    J Biochem Mol Biol; 2007 Sep; 40(5):678-83. PubMed ID: 17927900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C.
    Praticó D; Pasin M; Barry OP; Ghiselli A; Sabatino G; Iuliano L; FitzGerald GA; Violi F
    Circulation; 1999 Jun; 99(24):3118-24. PubMed ID: 10377074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of inhibition of platelet aggregation by HCL-31D.
    Chou TC; Li CY; Lee AR; Wu TM
    Eur J Pharmacol; 2000 Jan; 387(2):125-31. PubMed ID: 10650152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process.
    Chou TC; Li CY; Yen MH; Ding YA
    Biochem Pharmacol; 1999 Nov; 58(10):1657-63. PubMed ID: 10535758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
    Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
    Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
    J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets.
    Liao CH; Ko FN; Kuo SC; Teng CM
    Jpn J Pharmacol; 1998 Feb; 76(2):141-8. PubMed ID: 9541276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa.
    Sheu JR; Hung WC; Lee YM; Yen MH
    Eur J Pharmacol; 1996 Dec; 318(2-3):469-75. PubMed ID: 9016940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation.
    Wu TM; Li ML; Chou TC
    Thromb Res; 2000 Feb; 97(4):191-9. PubMed ID: 10674405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.